(Q38827745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Elena Cerrada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Elena García-Moreno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Alejandro Tomás

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sonia Gascón

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Eduardo Romanos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mary Jesus Rodriguez-Yoldi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mariano Laguna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

15 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

2462-2475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

A review on oxaliplatin-induced peripheral nerve damage.

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Metal-based anticancer chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Ruthenium(II) polypyridyl complexes and DNA--from structural probes to cellular imaging and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Polynuclear Ruthenium, Osmium and Gold Complexes. The Quest for Innovative Anticancer Chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Next-generation anticancer metallodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Anticancer metallotherapeutics in preclinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Transition metal based anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Titanium and vanadium complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

N-Heterocyclic carbene metal complexes in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Targeted delivery of platinum-based anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Gold compounds as therapeutic agents for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Noble metal-dithiocarbamates precious allies in the fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Phase II trial of titanocene dichloride in advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Titanium complexes in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Organometallic ruthenium(II) arene compounds with antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Bioorganometallic chemistry--from teaching paradigms to medicinal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Organometallic anticancer compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

The potential of organometallic complexes in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Metallocenes as Target Specific Drugs for Cancer Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Development of anticancer agents: wizardry with osmium

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Synthesis and biological evaluation of chromium bioorganometallics based on the antibiotic platensimycin lead structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

On the biological properties of alkynyl phosphine gold(I) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Synthesis and molecular recognition studies on small-molecule inhibitors for thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Characterization of site I on human serum albumin: concept about the structure of a drug binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Mixed ligand copper(II) complexes of 2,9-dimethyl-1,10-phenanthroline: tridentate 3N primary ligands determine DNA binding and cleavage and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Cytotoxic hydrophilic iminophosphorane coordination compounds of d⁸ metals. Studies of their interactions with DNA and HSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Green synthesis and physical characterization of Au nanoparticles and their interaction with bovine serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Interaction of cisplatin with human serum albumin. Drug binding mode and protein secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Cell cycle arrest by oxaliplatin on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

pRB plays an essential role in cell cycle arrest induced by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH2Ph)]Br.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Principles of Fluorescence Spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT01802A

21 January 2018

Identifiers

DOI

10.1039/C5DT01802A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26469679%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference